Status:
COMPLETED
ReActiv8 Post Market Surveillance Registry
Lead Sponsor:
Mainstay Medical
Conditions:
Chronic Low Back Pain
Eligibility:
All Genders
18+ years
Brief Summary
To gather data on the long-term safety of ReActiv8 and identify any residual risks by reporting all Serious Adverse Device Effects as well as performance and health care utilization through two years ...
Eligibility Criteria
Inclusion
- Meet the Indications for ReActiv8
- Willing to sign the Informed Consent for the Registry
- Age ≥ 18 years
Exclusion
- 1\. Subjects will be excluded from the Registry if they are contraindicated for ReActiv8.
Key Trial Info
Start Date :
October 9 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 8 2023
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT03255200
Start Date
October 9 2017
End Date
December 8 2023
Last Update
October 16 2024
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Orthopadisches Krankenhaus Schloss Werneck
Werneck, Balthasar-Neumann, Germany, 97440
2
BG Klinikum Bergmannstrost
Halle, Germany
3
Medizinisches Versorgungszentrum Steinburg gGmbH
Itzehoe, Germany
4
Katholisches Klinikum Koblenz
Koblenz, Germany